Cargando…

Effects of a Patient-Provider, Collaborative, Medication-Planning Tool: A Randomized, Controlled Trial

Among patients with various levels of health literacy, the effects of collaborative, patient-provider, medication-planning tools on outcomes relevant to self-management are uncertain. Objective. Among adult patients with type II diabetes mellitus, we tested the effectiveness of a medication-planning...

Descripción completa

Detalles Bibliográficos
Autores principales: Graumlich, James F., Wang, Huaping, Madison, Anna, Wolf, Michael S., Kaiser, Darren, Dahal, Kumud, Morrow, Daniel G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028848/
https://www.ncbi.nlm.nih.gov/pubmed/27699179
http://dx.doi.org/10.1155/2016/2129838
_version_ 1782454411152326656
author Graumlich, James F.
Wang, Huaping
Madison, Anna
Wolf, Michael S.
Kaiser, Darren
Dahal, Kumud
Morrow, Daniel G.
author_facet Graumlich, James F.
Wang, Huaping
Madison, Anna
Wolf, Michael S.
Kaiser, Darren
Dahal, Kumud
Morrow, Daniel G.
author_sort Graumlich, James F.
collection PubMed
description Among patients with various levels of health literacy, the effects of collaborative, patient-provider, medication-planning tools on outcomes relevant to self-management are uncertain. Objective. Among adult patients with type II diabetes mellitus, we tested the effectiveness of a medication-planning tool (Medtable™) implemented via an electronic medical record to improve patients' medication knowledge, adherence, and glycemic control compared to usual care. Design. A multicenter, randomized controlled trial in outpatient primary care clinics. 674 patients received either the Medtable tool or usual care and were followed up for up to 12 months. Results. Patients who received Medtable had greater knowledge about indications for medications in their regimens and were more satisfied with the information about their medications. Patients' knowledge of drug indication improved with Medtable regardless of their literacy status. However, Medtable did not improve patients' demonstrated medication use, regimen adherence, or glycemic control (HbA1c). Conclusion. The Medtable tool supported provider/patient collaboration related to medication use, as reflected in patient satisfaction with communication, but had limited impact on patient medication knowledge, adherence, and HbA1c outcomes. This trial is registered with ClinicalTrials.gov NCT01296633.
format Online
Article
Text
id pubmed-5028848
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-50288482016-10-03 Effects of a Patient-Provider, Collaborative, Medication-Planning Tool: A Randomized, Controlled Trial Graumlich, James F. Wang, Huaping Madison, Anna Wolf, Michael S. Kaiser, Darren Dahal, Kumud Morrow, Daniel G. J Diabetes Res Clinical Study Among patients with various levels of health literacy, the effects of collaborative, patient-provider, medication-planning tools on outcomes relevant to self-management are uncertain. Objective. Among adult patients with type II diabetes mellitus, we tested the effectiveness of a medication-planning tool (Medtable™) implemented via an electronic medical record to improve patients' medication knowledge, adherence, and glycemic control compared to usual care. Design. A multicenter, randomized controlled trial in outpatient primary care clinics. 674 patients received either the Medtable tool or usual care and were followed up for up to 12 months. Results. Patients who received Medtable had greater knowledge about indications for medications in their regimens and were more satisfied with the information about their medications. Patients' knowledge of drug indication improved with Medtable regardless of their literacy status. However, Medtable did not improve patients' demonstrated medication use, regimen adherence, or glycemic control (HbA1c). Conclusion. The Medtable tool supported provider/patient collaboration related to medication use, as reflected in patient satisfaction with communication, but had limited impact on patient medication knowledge, adherence, and HbA1c outcomes. This trial is registered with ClinicalTrials.gov NCT01296633. Hindawi Publishing Corporation 2016 2016-09-06 /pmc/articles/PMC5028848/ /pubmed/27699179 http://dx.doi.org/10.1155/2016/2129838 Text en Copyright © 2016 James F. Graumlich et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Graumlich, James F.
Wang, Huaping
Madison, Anna
Wolf, Michael S.
Kaiser, Darren
Dahal, Kumud
Morrow, Daniel G.
Effects of a Patient-Provider, Collaborative, Medication-Planning Tool: A Randomized, Controlled Trial
title Effects of a Patient-Provider, Collaborative, Medication-Planning Tool: A Randomized, Controlled Trial
title_full Effects of a Patient-Provider, Collaborative, Medication-Planning Tool: A Randomized, Controlled Trial
title_fullStr Effects of a Patient-Provider, Collaborative, Medication-Planning Tool: A Randomized, Controlled Trial
title_full_unstemmed Effects of a Patient-Provider, Collaborative, Medication-Planning Tool: A Randomized, Controlled Trial
title_short Effects of a Patient-Provider, Collaborative, Medication-Planning Tool: A Randomized, Controlled Trial
title_sort effects of a patient-provider, collaborative, medication-planning tool: a randomized, controlled trial
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028848/
https://www.ncbi.nlm.nih.gov/pubmed/27699179
http://dx.doi.org/10.1155/2016/2129838
work_keys_str_mv AT graumlichjamesf effectsofapatientprovidercollaborativemedicationplanningtoolarandomizedcontrolledtrial
AT wanghuaping effectsofapatientprovidercollaborativemedicationplanningtoolarandomizedcontrolledtrial
AT madisonanna effectsofapatientprovidercollaborativemedicationplanningtoolarandomizedcontrolledtrial
AT wolfmichaels effectsofapatientprovidercollaborativemedicationplanningtoolarandomizedcontrolledtrial
AT kaiserdarren effectsofapatientprovidercollaborativemedicationplanningtoolarandomizedcontrolledtrial
AT dahalkumud effectsofapatientprovidercollaborativemedicationplanningtoolarandomizedcontrolledtrial
AT morrowdanielg effectsofapatientprovidercollaborativemedicationplanningtoolarandomizedcontrolledtrial